Niels Peter Louis-Hansen — The Ledger

◼ Origin

Niels Peter Louis-Hansen (born 1947) is the son of Aage Louis-Hansen, who co-founded Coloplast A/S in 1957 after developing an ostomy-care solution for a nurse friend. Louis-Hansen inherited the controlling family stake in Coloplast and serves as its deputy chairman; his approximately 20.7% shareholding in the global medical device company underpins his $6B fortune.

◼ Self-Made Verdict — INHERITED

Inherited the controlling family stake in Coloplast from his father Aage Louis-Hansen; did not found the company.

◼ Documented marks

01

Largest individual shareholder (~20.7%) and deputy chairman of Coloplast A/S, a global medical device company operating in 140+ countries.

02

Largest individual shareholder (~20.7%) and deputy chairman of Coloplast A/S, a global medical device company operating in 140+ countries.

03

Holds approximately 15.6% of Ambu A/S, a Danish medical device company.

04

Holds approximately 15.6% of Ambu A/S, a Danish medical device company.

05

Chairman of the Aage and Johanne Louis-Hansen Foundation, one of Denmark's most active private scientific grant-making foundations.

06

Chairman of the Aage and Johanne Louis-Hansen Foundation, one of Denmark's most active private scientific grant-making foundations.

07

Maintains a low public profile; family owns historic Tustrup Manor near Randers, Denmark.

08

Maintains a low public profile; family owns historic Tustrup Manor near Randers, Denmark.

09

Coloplast's pelvic mesh products were reclassified Class III (high-risk) by the FDA in 2016 and banned from pelvic organ prolapse use in 2019.

10

Coloplast's pelvic mesh products were reclassified Class III (high-risk) by the FDA in 2016 and banned from pelvic organ prolapse use in 2019.